What is the total value of India's pharmaceutical export to Ireland?

India exported pharmaceuticals worth $27.3M to Ireland across 829 verified shipments.

Which companies in Ireland import pharmaceuticals from India?

1. MSD PHARMACEUTICALS PRIVATE LIMITED — $10.3M. 2. ALLERGAN INDIA PRIVATE LIMITED — $5.2M. 3. GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED — $3.5M. 105 buyers total.

What pharmaceutical products does India export most to Ireland?

1. Pembrolizumab ($11.0M, 40.3%); 2. Dexamethasone ($6.9M, 25.2%); 3. Serum ($3.6M, 13.0%); 4. Apixaban ($2.1M, 7.6%); 5. Tacrolimus ($469.1K, 1.7%)

Why does Ireland import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $27.3M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Ireland?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Ireland pharmaceutical trade?

$32.9K per consignment across 829 shipments.

How many Indian pharmaceutical companies export to Ireland?

113 Indian companies. Largest: MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, with $9.6M.

How can I find verified Indian pharmaceutical suppliers for Ireland?

TransData Nexus covers 113 active exporters with shipment history and trade values at transdatanexus.com.

Ireland to India Pharmaceutical Import (2026) — $27.3M, 113 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Ireland?

1. MERCK SHARP & DOHME ASIA PACIFIC SERVICES PTE LTD, — $9.6M. 2. ALLERGAN PHARMACEUTICALS INTERNATIONAL — $5.2M. 3. GRIFOLS WORLDWIDE OPERATION LTD. — $3.5M. Total: 113 suppliers.

Ireland to India Pharmaceutical Import (2026) — $27.3M, 113 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Ireland to India

#	Formulation	Value	Share
1	Pembrolizumab	$11.0M	40.3%
2	Dexamethasone	$6.9M	25.2%
3	Serum	$3.6M	13.0%
4	Apixaban	$2.1M	7.6%
5	Tacrolimus	$469.1K	1.7%
6	Sodium	$343.7K	1.3%
7	Vaccine	$317.6K	1.2%
8	Dasatinib	$286.3K	1.0%
9	Amphotericin	$256.7K	0.9%
10	Pomalidomide	$231.1K	0.8%
11	Pazopanib	$225.0K	0.8%
12	Ustekinumab	$218.3K	0.8%
13	Salbutamol	$158.9K	0.6%
14	Carfilzomib	$113.2K	0.4%
15	Heparin	$84.8K	0.3%

India imports 20+ pharmaceutical formulations from Ireland with a combined trade value of $27.3M. Key products include Pembrolizumab ($11.0M), Dexamethasone ($6.9M), Serum ($3.6M), Apixaban ($2.1M), Tacrolimus ($469K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 829 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Ireland to India Trade Routes

1Pembrolizumab$11.0M

2Dexamethasone$6.9M

3Serum$3.6M

4Apixaban$2.1M

5Tacrolimus$469K

6Sodium

Top Ireland Suppliers to India

1Merck Sharp & Dohme Asia Pacific Services Pte Ltd,

$9.6M

2Allergan Pharmaceuticals International

$5.2M

3Grifols Worldwide Operation Ltd.

$3.5M

4Pfizer Service Company Bv

$2.3M

5Merck Sharp Dohme Asia Pacific Services Pte Ltd

$915K

Trade Statistics

Total Value$27.3M

Shipments829

Indian Exporters113

Ireland Buyers105

Avg Shipment$33K

Products101

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Ireland Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Ireland and India has experienced significant growth from 2022 to 2026. In 2022, the total import value was approximately $5.5 million USD, with 150 shipments from 50 Irish suppliers to 60 Indian buyers. By 2026, these figures had increased to a total import value of $27.3 million USD, encompassing 829 shipments from 113 Irish suppliers to 105 Indian buyers. This growth underscores the strengthening trade relations and the expanding role of Ireland in India's pharmaceutical sector.

2Ireland's Role in India's Pharma Imports

Ireland's contribution to India's pharmaceutical imports has been steadily increasing. In 2024, Ireland exported pharmaceutical products worth $22.61 million USD to India, accounting for approximately 2.3% of India's total pharmaceutical imports. This positions Ireland as a significant supplier, particularly in the domains of biologics and specialty medicines. The top products imported from Ireland include Pembrolizumab, Dexamethasone, and Serum, indicating a focus on advanced therapies and critical care medications.

3Recent Developments

Ireland Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For Irish pharmaceutical companies seeking to import products into India, obtaining approval from the CDSCO is mandatory. The process involves several key steps:

1. Online Registration: Applicants must register on the CDSCO's online portal, providing details such as applicant type, organization name, and contact information.

2. Document Submission: Essential documents include a Certificate of Pharmaceutical Product (COPP) from the country of origin, a Good Manufacturing Practice (GMP) certificate, and a free sale certificate.

3. Application Review: CDSCO evaluates the application to ensure compliance with Indian standards. This may involve site inspections and consultations with subject-matter experts.

4. Approval: Upon successful evaluation, CDSCO grants approval, allowing the product to be marketed and sold in India.

The entire process can take several months, depending on the completeness of the application and the efficiency of the review process.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to stringent GMP standards, ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. Manufacturing facilities must obtain GMP certification, which signifies compliance with these standards. The CDSCO conducts inspections to verify adherence to GMP guidelines, and products from WHO-prequalified facilities are often given priority in the approval process.

3Import Documentation

Importing pharmaceutical products into India necessitates the following documentation:

Import License (Form 10): Issued by CDSCO, this license authorizes the import of specific pharmaceutical products.

Registration Certificate: Confirms that the product has been approved by CDSCO for sale in India.

No Objection Certificate (NOC): Required from the Ministry of Health and Family Welfare, indicating no objection to the import.

Test License: Allows for the testing of imported pharmaceutical products to ensure they meet Indian standards.

Customs Procedures: Compliance with Indian customs regulations, including proper labeling and packaging, is essential for the clearance of pharmaceutical imports.

TransData Nexus Research · Ireland regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Ireland identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 829 verified shipments from 113 Indian exporters to 105 Ireland buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

113 Exporters

105 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Ireland to India Pharmaceutical Import

Top Pharmaceutical Formulations — Ireland to India

Top Pharmaceutical Products — Ireland to India Trade Routes

Top Ireland Suppliers to India

Trade Statistics

Other Import Origins

India–Ireland Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Ireland's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Ireland

Product Routes

Full Dataset Access

Ireland Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Ireland

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Ireland

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Ireland Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Ireland for Indian Pharma

1India's Import Dependency

FAQ — India to Ireland Pharmaceutical Trade